Discover how safely we lead our customers through early stage product development research and fully customized in-vivo and in-vitro studies. View more
See how we monitor and support the planning and set-up of studies at an early stage. View more
Experience how we always strive for the best solution, generating tailor-made products and services in drug research and testing. View more
Find out, why we consider ourselves as our clients extended arm in drug development, fast, efficient and interdisciplinary. View more
Discover our turnkey preclinical package solutions being entirely customized to customer needs. View more
Feel the dedication and passion for our customers.
Discover how our advisory team stands at their side on the way to future success. View more
Explore our culture of direct communication in which scientist talk with scientists, from the first contact until the final document. View more
Dear valued customer, As you may know, due to the spread of the COVID-19, restrictive measures were introduced in all…
View moreMeet us at BioFIT in Marseille on 10-11 December! Dr. Tamás Kitka, BD manager will be attending. See you there!
View moreMeet in Italy for Life Sciences is an initiative by the ALISEI National Technology Cluster for Life Sciences.The event, founded…
View moreThe Aurigon Group proudly announce a new paper co-authored by our colleague, Tamas Kitka in his previous position. The article,…
View moreThe European Medicines Agency has recently published a wonderful and comprehensive booklet entitled “From laboratory to patient: the journey of…
View moreSource: Nature. By: Nobuyuki Tanaka, Shigeaki Kanatani [...] Peter Uhlén. Intratumoral heterogeneity is a critical factor when diagnosing and treating patients with…
View more